{"result": "(\"entity\"<|>ACCORD<|>EVENT<|>The ACCORD study is a clinical trial that investigated the effects of intensive glucose lowering in type 2 diabetes over a period of 3.5 years.)\n##\n(\"entity\"<|>DIABETES MELLITUS<|>ORGANIZATION<|>Diabetes Mellitus is a chronic condition that affects how the body processes blood sugar (glucose) and is the focus of various studies and treatment guidelines.)\n##\n(\"entity\"<|>AMERICAN DIABETES ASSOCIATION<|>ORGANIZATION<|>The American Diabetes Association is a leading organization in the United States that provides information and resources for diabetes management and research.)\n##\n(\"entity\"<|>SPANISH SOCIETY OF ENDOCRINOLOGY AND NUTRITION<|>ORGANIZATION<|>The Spanish Society of Endocrinology and Nutrition is a professional organization that focuses on the study and treatment of endocrine disorders, including diabetes.)\n##\n(\"entity\"<|>WORKGROUP OF THE AMERICAN DIABETES ASSOCIATION AND THE ENDOCRINE SOCIETY<|>ORGANIZATION<|>This workgroup is a collaborative effort to address issues related to diabetes management and hypoglycemia.)\n##\n(\"entity\"<|>GLUT4<|>ORGANIZATION<|>GLUT4 is a glucose transporter protein that plays a key role in glucose uptake in response to insulin, particularly in muscle and fat tissues.)\n##\n(\"entity\"<|>HYPOGLYCEMIA<|>EVENT<|>Hypoglycemia is a condition characterized by abnormally low blood sugar levels, which can lead to various symptoms and complications, especially in diabetic patients.)\n##\n(\"relationship\"<|>ACCORD<|>DIABETES MELLITUS<|>The ACCORD study focuses on the management and treatment of Diabetes Mellitus through intensive glucose lowering strategies.<|>8)\n##\n(\"relationship\"<|>AMERICAN DIABETES ASSOCIATION<|>DIABETES MELLITUS<|>The American Diabetes Association provides guidelines and resources for the management of Diabetes Mellitus.<|>7)\n##\n(\"relationship\"<|>SPANISH SOCIETY OF ENDOCRINOLOGY AND NUTRITION<|>DIABETES MELLITUS<|>The Spanish Society of Endocrinology and Nutrition conducts research and provides guidelines related to Diabetes Mellitus.<|>7)\n##\n(\"relationship\"<|>WORKGROUP OF THE AMERICAN DIABETES ASSOCIATION AND THE ENDOCRINE SOCIETY<|>DIABETES MELLITUS<|>This workgroup addresses diabetes management issues, including hypoglycemia, which is a significant concern for patients with Diabetes Mellitus.<|>6)\n##\n(\"relationship\"<|>GLUT4<|>HYPOGLYCEMIA<|>GLUT4 is involved in glucose uptake, and its dysfunction can lead to hypoglycemia in diabetic patients.<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: fármacos empleados en su tratamiento (destacando aquellos que contienen el grupo\n        la concentración total de los GLUT4. Así, podemos observar que los deportistas que entrnan                                                       sulfhidrilo), que alterarían de algún modo la molécula de insulina confiriéndole mayor inmu-\n        diariamente tienen una mayor capacidad de almacenar glucógeno muscular (además detener                                                           nogenicidad y disminuyendo, a la vez, su actividad biológica.\n        más cantidad de músculo) y a la vez poseen más cantidadde GLUT4. A mayores demandas de                                                           La hipoglucemia asociada con fallo autonómico puede predisponer a la aparición de arrit-\n        energía que provoquen la utilización y la disminución del glucógeno muscular, mayor tenden-                                                      mias cardíacas en pacientes con diabetes. La mayor evidencia procede de estudios con\n        cia a la sobrecompensación, por lo que la célula aumenta la transcripción y la traducción de                                                     hipoglucemia experimental, en los que la hipoglucemia induce cambios en la repolarización\n        GLUT4, así como su translocación hacia la membrana celular, lo que llevaría a un aumento en                                                      y arritmias tanto en DM1 como en DM2.\n        las reservas de glucógeno, supercompensación que suele darse en los deportistas.\n        En el estudio ACCORD, en comparación con la terapia estándar, el uso de terapia intensiva                                                        Referencias:\n                                                                                                                                                         • Mezquita-Raya P, Reyes-García R, Moreno-Pérez O, Muñoz-Torres M, Merino-Torres JF, Gorgojo-Martínez JJ, et al. Diabetes Mellitus\n        para alcanzar los niveles normales de hemoglobina glicada durante 3,5 años aumentó la                                                              Working Group of the Spanish Society of Endocrinology\n                                                                                                                                                           and Nutrition (SEEN). Documento de posicionamiento: evaluación y manejo de la hipoglucemia en el paciente con diabetes mellitus.\n        mortalidad y no redujo significativamente los eventos cardiovasculares mayores.                                                                    Endocrinol Nutr. 2013;60(9):517.e1-18.\n                                                                                                                                                         • Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, et al. Hypoglycemia and diabetes: a report of a workgroup of the\n        Referencias:                                                                                                                                       American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36:1384-95.\n        • Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB,            • Taylor SI, Barbetti F, Accili D, Roth J, Gorden G. Syndromes of autoimmunity and hypoglycemia. Endocrinol Metab Clin North Am.\n          et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545-59. doi: 10.1056/NEJMoa0802743.                 1989;18:123-43.\n        • Gómez-Zorita S, Urdampilleta A. El GLUT4: efectos de la actividad física y aspectos nutricionales en los mecanismos de captación\n          de glucosa y sus aplicaciones en la diabetes tipo 2. Av Diabetol. 2012;28(1):19-26.\n\n\n\n96                                                                                                                                                                                                                                                                                    97\n---\n                                                                                                                                                                                                                        DIABETES                         2\n\n\n\n    31  Actualmente, tanto a nivel internacional (Workgroup of the American Diabetes                                                     mal control glucémico pueden experimentar síntomas de hipoglucemia con niveles de\n        Association and The Endocrine Society) como nacional (Grupo de Trabajo de                                                        glucosa en plasma superiores a 70 mg/dl.\n        Diabetes Mellitus de la Sociedad Española de Endocrinología y Nutrición), el punto\n        de corte para considerar en riesgo de hipoglucemia a un paciente diabético en                                               Tabla 3. Características clínicas de las descompensaciones agudas de la diabetes\n        tratamiento con hipoglucemiantes se ha establecido:                                                                                                                                             CAD\n                                                                                                                                                                                   CAD leve          moderada           CAD grave             SHH\n        A. En menor o igual a 45 mg/dl.\n        B. En menor o igual a 50 mg/dl.                                                                                               Glucosa plasmática (mg/dl)                     >250               >250               >250              >600\n        C. En menor o igual a 60 mg/dl.                                                                                               pH arterial                                 7,25 a 7,30        7,00 a 7,24           <7,00             >7,30\n        D.  En menor o igual a 70 mg/dl.                                                                                              Bicarbonato sérico (mEq/l)                    15 a 18           10 a <15              <10               >18\n                                                                                                                                      Cetonuria                                    Positiva           Positiva           Positiva        Baja-mínima\n        COMENTARIO                                                                                                                    Cetonemia-beta hidroxibutirato             3 a 4 mmol/l\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}